EMEA-001739-PIP02-16-M01 - paediatric investigation plan
ketamine (hydrochloride)
sufentanil citrate
PIPHuman
Cessatech A/S
E-mail: info@cessatech.com
Tel: +45 93872309
P/0177/2022 : EMA decision of 13 May 2022 on the acceptance of a modification of an agreed paediatric investigation plan for sufentanil (citrate) / ketamine (hydrochloride) (EMEA-001739-PIP02-16-M01)